While there have been many significant advances in healthcare in the past 25 years, including new treatments for cancer ...

Sonnet BioTherapeutics (SONN) announced an expansion of its Phase 1 SB101 clinical study of SON-1010 in adult patients with advanced solid ...

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced ...

The Arkansas Integrative Metabolic Research Center will host Jeffrey Rathmell, a professor of pathology, microbiology and immunology from Vanderbilt University on Wednesday, Jan. 22.